TAK
TAKEDA PHARMACEUTICAL CO LTD
NYSE: TAK · Tokyo, M0 · Healthcare
$15.72-0.02 (-0.13%)Closed
Market Cap$24.49B
Cash—most recent
Runway—
P/E (TTM)—
52-Wk Range$13.23 – $18.80
Avg Volume3.1M3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$15.72+21.8%
Pipeline
Drug candidates sponsored by TAKEDA PHARMACEUTICAL · ClinicalTrials.gov
No trials found for this sponsor.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for TAK. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.